Schoeneweis escapes discipline
MLB will not suspend lefty for role in performance-enhancers
NEW YORK -- The Mets bullpen has dodged a bullet. Scott Schoeneweis, signed by the Mets in January, will not be disciplined by Major League League baseball for his involvement with performance-enhancing substances.
The Mets reliever was one of four big league players linked to performance-enhancers, but not disciplined, because MLB's investigation found "insufficient evidence'' they had used the substances they had received prior to 2005.
Reports in September and October implicated Schoeneweis; third baseman Troy Glaus of the Blue Jays; and outfielders Gary Matthews Jr. of the Angels, Rick Ankiel of the Cardinals, Jay Gibbons of the Orioles and Jose Guillen, now of the Royals. Gibbons and Guillen have been suspended for 15 days at the beginning of the season for violating MLB's Joint Drug Prevention and Treatment Program.
Schoeneweis has denied receiving shipments and said that he was not familiar with Signature Pharmacy.
Reports had Schoeneweis, a survivor of testicular cancer, receiving steroid shipments from Signature Pharmacy while playing for the White Sox in 2003 and 2004. ESPN reported that Schoeneweis' name had appeared on packages sent to U.S. Cellular Field in those years.
Invoices indicated Schoeneweis had spent $1,160 on the drugs, the report said. Packages he received on May 23 and June 25, 2003, contained 10 milliliter bottles of testosterone and stanozolol. The package sent on Sept. 3 had twice as much stanozolol. The last three shipments -- Nov. 18, 2003, April 15, 2004 and June 24, 2004 -- contained one 10-milliliter bottle of testosterone.
The report said Dr. Ramon Scruggs of the New Hope Health Center in Tustin, Calif., prescribed the drugs for Schoeneweis and Glaus. Scruggs, the report said, subsequently was suspended by California's state medical board on charges that he prescribed 6,073 prescriptions of dangerous drugs or controlled substances over the Internet without a good faith examination of the patients.
Now 33, Schoeneweis signed a three-year, $10.8 million, contract with the Mets before the 2007 season.
He is the second Mets player implicated. Guillermo Mota, traded to the Brewers last month, served a 50-game suspension at the beginning of last season for violating MLB's program.
Marty Noble is a reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.